Buscar
Mostrando ítems 1-10 de 39
Intermittent PTH1-34 Causes DNA and Chromosome Breaks in Osteoblastic and Nonosteoblastic Cells
(Springer, 2010-11-01)
Toxicological studies have demonstrated that intermittent PTH1-34 treatment is associated with an increased incidence of osteosarcoma in Fischer 344 rats. Comet and micronucleus (MN) tests, standard methods to evaluate ...
Intermittent Parathyroid Hormone Administration Improves Periodontal Healing in Rats
(Amer Acad PeriodontologyChicagoEUA, 2014)
Efeitos da vibração mecânica associada ao iPTH no tecido ósseo de ratas sob privação estrogênica
(Universidade Federal de São Paulo (UNIFESP), 2018-12-20)
Objetivo: Investigar os efeitos da Vibração Mecânica combinada ao iPTH ou
administrada após a descontinuação deste medicamento na matriz óssea de ratas sob
privação estrogênica. Métodos: Cinquenta e quatro ratas Wistar ...
Paratormônio e osteoporose: encontrando o fio da meada. Bases fisiológicas para utilização do PTH no tratamento da osteoporose
(Sociedade Brasileira de Endocrinologia e Metabologia, 2002-06-01)
Parathyroid hormone (PTH) will be available in a few months for the treatment of osteoporosis. When used as a single daily subcutaneous injection for at least 1 year, it increases bone mass and reduces fracture rate more ...
Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats
(Pergamon-elsevier Science LtdOxfordInglaterra, 2005)
Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice
(ELSEVIER SCIENCE INC, 2008)
Matricellular proteins play a unique role in the skeleton as regulators of bone remodeling, and the matricellular protein osteonectin (SPARC, BM-40) is the most abundant non-collagenous protein in bone In. the absence of ...